通过RNA干扰阻断体质重复扩张和降低亨廷丁,协同防止在小鼠中亨廷顿病的发病
Jillian Belgrad1, Ashley Summers1, Christian Landles2
1UMass Chan Medical School, RNA Therapeutics Institute, Worcester, MA, USA, 01605.
bioRxiv : the preprint server for biology
|July 16, 2025
概括
亨廷顿病 (HD) 疗法可以通过向体扩张来改善. 在HD小鼠中同时抑制MSH3和huntingtin (HTT) 逆转了疾病标志物,并没有显示出毒性.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 亨廷顿病 (HD) 是一种进展性神经退行性疾病,缺乏经批准的治疗方法.
- CAG重复体扩张和突变亨廷丁 (mHTT) 是HD中神经元功能障碍的关键驱动因素.
- 目前的降低HTT的策略在试验中产生了有限的临床益处.
研究的目的:
- 为了评估沉默MSH3,HTT或两者的长期影响,在HD小鼠模型中使用治疗双价siRNAs.
- 为了确定通过MSH3抑制向体扩张是否可以改善HD病理.
- 评估结合MSH3和HTT沉默治疗疾病的安全性和有效性.
主要方法:
- 利用了Q111 HD小鼠,其特点是显著的CAG重复扩张,mHTT含入和转录失调.
- 使用RNA干扰 (RNAi) 疗法对MSH3,HTT或两者进行长期沉默.
- 评估结果包括CAG重复扩张,mHTT含量水平,基因表达变化和野生类型小鼠的潜在毒性.
主要成果:
- 长期的MSH3沉默有效地阻止了体的扩张,减少了mHTT的包含,并逆转了HD小鼠的基因表达异常.
- 单个HTT静音显示出最小的影响,而联合MSH3/HTT准协同消除了包含和规范化转录组形状.
- 在接受并行治疗的野生类型小鼠中没有检测到可观察到的毒性,这表明了有利的安全性.
结论:
- 身体扩张代表了亨廷顿病的可行的治疗点.
- 基于RNAi的MSH3和HTT的协同沉默为HD提供了一个有希望的疾病修饰策略.
- 双重向MSH3和HTT表明了协同效应和长期治疗性干预的潜力.
更多相关视频
10:52Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
Published on: December 10, 2021
2.6K
06:51Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
7.8K
相关概念视频
02:15Experimental RNAi
6.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K
01:23RNA Interference
26.5K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.5K
02:30siRNA - Small Interfering RNAs
17.0K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.0K
01:16In-vitro Mutagenesis
14.2K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
14.2K